Galderma Announces New Data Demonstrating the Positive Anti-Inflammatory Effect and Mode of Action of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis

Results from transcriptomic (RNA Gene Expression) data now published in the Journal of Allergy and Clinical Immunology: Read More